Drug Profile
APC 8020
Alternative Names: APC8020; Multiple myeloma vaccine - Dendreon; Myeloma vaccine - Dendreon; MylovengeLatest Information Update: 22 Mar 2012
Price :
$50
*
At a glance
- Originator Dendreon Corporation
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Amyloidosis; Multiple myeloma
Most Recent Events
- 11 Oct 2004 No development reported - Phase-I for Multiple myeloma in Japan (unspecified route)
- 11 Oct 2004 No development reported - Phase-II for Amyloidosis in USA (unspecified route)
- 11 Oct 2004 No development reported - Phase-II for Multiple myeloma in USA (unspecified route)